NDAORALCAPSULE
Approved
May 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
SODIUM IODIDE I 123 (sodium iodide i 123) by Integrated Biosciences is clinical pharmacology sodium iodide i 123 is readily absorbed from the upper gastrointestinal tract. First approved in 1982.
Drug data last refreshed 11h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Sodium Iodide I-123 is a radioactive diagnostic agent administered orally as a capsule for thyroid imaging and functional assessment. It is absorbed from the gastrointestinal tract and selectively accumulated by the thyroid gland, allowing visualization of thyroid anatomy and detection of normal versus abnormal tissue function. The drug works by being trapped and organically bound by thyroid tissue, enabling clinicians to measure thyroid uptake and map glandular distribution patterns.
LOE Approaching
As a mature diagnostic with approaching loss of exclusivity and moderate competitive pressure (30%), the brand team is likely focused on retention strategies rather than expansion.
Mechanism of Action
CLINICAL PHARMACOLOGY Sodium Iodide I 123 is readily absorbed from the upper gastrointestinal tract. Following absorption, the iodide is distributed primarily within the extracellular fluid of the body. It is trapped and organically bound by the thyroid and concentrated by the stomach, choroid…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Careers linked to Sodium Iodide I-123 are concentrated in field-based technical roles with minimal headcount and limited upward mobility. This represents a maintenance-phase product with shrinking organizational footprint and reduced career development prospects.
Worked on SODIUM IODIDE I 123 at Integrated Biosciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.